{"sector": "Healthcare", "fullTimeEmployees": 726, "longBusinessSummary": "CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides; and DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. It also develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; TB Booster for the BCG-vaccinated population; and Ad5-nCov, a recombinant novel coronavirus disease vaccine. In addition, the company is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB105 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc. to develop a mRNA lipid nanoparticle vaccine against COVID-19. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the People's Republic of China.", "city": "Tianjin", "phone": "86 22 5821 3600", "country": "China", "companyOfficers": [], "website": "http://www.cansinotech.com", "maxAge": 1, "address1": "401-420, Biomedical Park", "fax": "86 22 5821 3677", "industry": "Drug Manufacturers\u2014Specialty & Generic", "address2": "4th Floor 185 South Avenue TEDA West District", "ebitdaMargins": 0.18833, "profitMargins": 0.30864, "grossMargins": 0.6928, "operatingCashflow": 530745888, "revenueGrowth": null, "operatingMargins": 0.17645, "ebitda": 392168544, "targetLowPrice": null, "recommendationKey": "none", "grossProfits": 10159488, "freeCashflow": 81959240, "targetMedianPrice": null, "currentPrice": 205.8, "earningsGrowth": null, "currentRatio": 2.92, "returnOnAssets": 0.038399998, "numberOfAnalystOpinions": null, "targetMeanPrice": null, "debtToEquity": 12.828, "returnOnEquity": 0.15314001, "targetHighPrice": null, "totalCash": 6711691776, "totalDebt": 900073024, "totalRevenue": 2082315776, "totalCashPerShare": 27.123, "financialCurrency": "CNY", "revenuePerShare": 8.564, "quickRatio": 2.629, "recommendationMean": null, "exchange": "HKG", "shortName": "CANSINOBIO-B", "longName": "CanSino Biologics Inc.", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "isEsgPopulated": false, "gmtOffSetMilliseconds": "28800000", "underlyingSymbol": null, "quoteType": "EQUITY", "symbol": "6185.HK", "underlyingExchangeSymbol": null, "headSymbol": null, "messageBoardId": "finmb_108945349", "uuid": "e66e6533-d8eb-3c20-bef5-8bd8a5a13bfa", "market": "hk_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 24.779, "beta3Year": null, "enterpriseToEbitda": 131.568, "52WeekChange": null, "morningStarRiskRating": null, "forwardEps": null, "revenueQuarterlyGrowth": null, "sharesOutstanding": 132671000, "fundInceptionDate": null, "annualReportExpenseRatio": null, "totalAssets": null, "bookValue": 24.494, "sharesShort": null, "sharesPercentSharesOut": null, "fundFamily": null, "lastFiscalYearEnd": 1609372800, "heldPercentInstitutions": 0.48154, "netIncomeToCommon": 642696384, "trailingEps": null, "lastDividendValue": null, "SandP52WeekChange": null, "priceToBook": 8.402058, "heldPercentInsiders": 0.26222, "nextFiscalYearEnd": 1672444800, "yield": null, "mostRecentQuarter": 1625011200, "shortRatio": null, "sharesShortPreviousMonthDate": null, "floatShares": 133229500, "beta": -0.653201, "enterpriseValue": 51596759040, "priceHint": 3, "threeYearAverageReturn": null, "lastSplitDate": null, "lastSplitFactor": null, "legalType": null, "morningStarOverallRating": null, "earningsQuarterlyGrowth": null, "priceToSalesTrailing12Months": 31.826067, "dateShortInterest": null, "pegRatio": null, "ytdReturn": null, "forwardPE": null, "lastCapGain": null, "shortPercentOfFloat": null, "sharesShortPriorMonth": null, "category": null, "fiveYearAverageReturn": null, "previousClose": 200.6, "regularMarketOpen": 198.6, "twoHundredDayAverage": 308.53885, "trailingAnnualDividendYield": null, "payoutRatio": 0, "volume24Hr": null, "regularMarketDayHigh": 208, "navPrice": null, "averageDailyVolume10Day": 1145186, "regularMarketPreviousClose": 200.6, "fiftyDayAverage": 236.53824, "trailingAnnualDividendRate": null, "open": 198.6, "averageVolume10days": 1145186, "expireDate": null, "algorithm": null, "dividendRate": null, "exDividendDate": null, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 198.1, "currency": "HKD", "regularMarketVolume": 509300, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 66271920128, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 1093029, "dayLow": 198.1, "ask": 206.2, "askSize": 0, "volume": 509300, "fiftyTwoWeekHigh": 449.6, "fromCurrency": null, "fiveYearAvgDividendYield": null, "fiftyTwoWeekLow": 145.1, "bid": 205.8, "tradeable": false, "dividendYield": null, "bidSize": 0, "dayHigh": 208, "regularMarketPrice": 205.8, "preMarketPrice": null, "logo_url": "https://logo.clearbit.com/cansinotech.com"}